Figure 1.
Effects of CM and mycelial fermentation (MF) on the viability of 3T3 fibroblasts and cancer cells. 3T3 fibroblasts (a), MCF-7 breast cancer cells (b), GBM8401 (c), and U-87MG (d) glioblastoma cells were treated with either CM or MF at a concentration of 0.5, 1, 1.5, 2, and 2.5 mg/ml and incubated for 24 h. The cell viability was monitored by using MTT assay. Data are means±S.D. of five independent experiments (P<0.05)
